Mold-Tek Packaging Limited links consolidation to EBITDA growth

Mold-Tek Packaging Limited said consolidating five plants into two locations translated into better EBITDA growth. The company reported H1 FY27 EBITDA of Rs 107.70 crore, up 24% year on year, while its single-roof label operation increased capacity by 50% and produced 20% more labels.

How did Mold-Tek consolidate its manufacturing footprint?

Mold-Tek consolidated five plants into two locations during the year under its capacity-optimisation programme, and management said the change translated into better EBITDA growth. The presentation does not identify the five plants or the two locations, but places the action alongside a focus on improving capacity utilisation.

The company describes its network as 10 manufacturing units and one stock point across India, with injection-moulding capacity of more than 66,900 tonnes per annum. It said it proactively forecasts capacity that could become idle, then supports order booking through low minimum order quantity, or MOQ, orders, new-industry business and production sequencing.

H1 FY27 sales volume rose 8% year on year to 23,117 metric tonnes, while EBITDA rose 24% to Rs 107.70 crore. EBITDA therefore increased faster than volume in the half year, although management cited several drivers, including cost control, lower process wastage, single-roof in-mould labelling and rising pharma sales contribution.

What changed in Mold-Tek’s label-making operations?

Mold-Tek brought all label-making activities under one roof and said the move created measurable economies of scale. The company raised label-making capacity by 50%, added offset printing technology and strengthened the team operating the centralised facility.

The operation also introduced an artificial-intelligence-based inspection system. Mold-Tek said it produced 20% more labels and 37% more stock-keeping units, or SKUs, during the year, with better turnaround time, or TAT; the larger SKU increase indicates a broader product mix alongside higher label output.

In-mould labelling, or IML, is part of Mold-Tek’s backward-integrated packaging model. The presentation lists more than 180 injection machines and more than 1,000 moulds and robots made in-house, while describing its high-definition photographic IML labels as produced through 100% hands-free operation and 100% recyclable.

Management included bringing IML making under a single roof among the factors that unlocked value in H1 FY27. It separately identified cost control, process-wastage reduction, capacity utilisation and pharma sales as EBITDA drivers, rather than assigning the reported 24% EBITDA growth to label centralisation alone.

Which Mold-Tek segments supported growth in the first half?

Mold-Tek reported 32% pharma growth in the first half and said the segment achieved its Year 2 targets. It added squeeze-lock child-resistant closures, or CRC, and vial holders as two product lines, while onboarding multiple clients and reporting encouraging leads across its pharma product mix.

Food and fast-moving consumer goods, or FMCG, thin-wall packaging grew 40%, exceeding the reported 32% pharma growth. Mold-Tek installed food and FMCG capacity at Panipat and started supplies, and management said leads from northern India could drive this segment over the next two to three years.

Bulk packs showed a different demand pattern. Mold-Tek cited a revival in paint and support from its Q Pack segment, established RCPP and said it had streamlined the related manufacturing process; it also referred to adoption of IML and heat-transfer labelling, or HTL, by the paint industry.

Lubricant-pack sales were affected by public-sector undertaking, or PSU, tenders and a general industry decline, according to the presentation. This contrasts with the disclosed 40% thin-wall and 32% pharma growth, showing that the operating programme covered segments facing differing demand conditions.

How did Mold-Tek’s H1 FY27 financial growth compare with volume?

Mold-Tek reported H1 FY27 revenue of Rs 574.68 crore, up 28% year on year, EBITDA of Rs 107.70 crore, up 24%, and profit after tax, or PAT, of Rs 46.64 crore, up 23%. Each reported financial measure grew faster than the 8% sales-volume increase to 23,117 metric tonnes.

Q2 FY27 revenue was Rs 274.23 crore, EBITDA was Rs 51.27 crore and PAT was Rs 21.07 crore. The presentation reported year-on-year growth of 31%, 30% and 36%, respectively, for the quarter, compared with H1 growth of 28%, 24% and 23%.

For FY26, Mold-Tek reported revenue of Rs 886.61 crore, EBITDA of Rs 173.66 crore and PAT of Rs 72.87 crore. The presentation provides a full-year FY26 figure and a first-half FY27 figure, so these periods are not directly comparable as like-for-like operating periods.

How far has Mold-Tek’s automation programme progressed?

Mold-Tek said its enterprise resource planning, or ERP, implementation covers six of eight departments. Management said the ERP system is intended to improve data handling and dashboards, enabling better forecasting and quicker decision-making in the departments covered.

The company is implementing artificial-intelligence-based camera inspection systems for defect detection and dimensional certainty. This follows the artificial-intelligence inspection system introduced in label making, but the presentation does not quantify cost savings, defect reduction or a completion date for the camera rollout.

Mold-Tek has initiated automation in quality control, ink mixing, finished-goods handling and lid printing. It also introduced laser-engravable IML and metallised IML, optimised cycle times and introduced low-weight packs as part of its research and development activity.

The company entered an understanding with UK-based Vibe Generation LLP to develop and commercialise intellectual-property-based precision caps and closures. Mold-Tek said it is developing value-adding solutions for customers in pharma, food, FMCG and paints through product design, decoration and promotional launches.

Conclusion

Mold-Tek’s disclosed operating overhaul combines the consolidation of five plants into two locations, a centralised label operation and automation in inspection and production-support processes. H1 FY27 revenue, EBITDA and PAT rose 28%, 24% and 23%, respectively, while sales volume increased 8%, and management linked utilisation, label centralisation and cost actions to the EBITDA outcome.

What to watch next is the ERP rollout beyond the six of eight departments already covered and implementation of artificial-intelligence camera inspection systems. Management also identified Panipat food and FMCG supplies, northern-region leads over the next two to three years, and the Vibe Generation LLP arrangement on precision caps and closures as disclosed development areas.